First‐line therapy of bevacizumab plus chemotherapy versus cetuximab plus chemotherapy for metastatic colorectal cancer patients with mucinous adenocarcinoma or mucinous component

BACKGROUND: To compare the efficacy of first‐line bevacizumab plus chemotherapy with cetuximab plus chemotherapy based on the stratification of metastatic colorectal cancer (mCRC) patients with mucinous adenocarcinoma (MA) or mucinous component (MC). METHODS: A retrospective study involving all mCRC...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Med
Glavni autori: Zhou, Yu‐Wen, Long, Yi‐Xiu, Chen, Ye, Liu, Ji‐Yan, Pu, Dan, Huang, Jia‐Yan, Bi, Feng, Li, Qiu, Gou, Hong‐Feng, Qiu, Meng
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2021
Teme:
Cancer Biology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8124114/
https://ncbi.nlm.nih.gov/pubmed/33939281
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3876
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items